Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349854 · ClinicalTrials.gov registry record
Neurobiology of the Scalp in Seborrheic Dermatitis
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 32
- Enrollment target
NCT02349854: Completed study, sponsored by Boston University.
NCT02349854 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02349854 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
Seborrheic dermatitis is a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp or inside the ear. These scales can occur with or without underlying reddened skin. In addition to causing psychological distress, low self esteem, and embarrassment, seborrheic dermatitis is associated with scalp pruritus (itch). Treatment modalities exist to control scalp flaking and itch associated with seborrheic dermatitis, although such therapies often lose efficacy over time. As seborrheic dermatitis is a chronic (life-long) condition, better treatments are needed. The investigators propose to better characterize in subjects with seborrheic dermatitis involving the scalp versus normal scalp controls: (a) the clinical characteristics of the associated itch and (b) the pattern of nerve innervation to the scalp. In this way, the investigators hope to get a comprehensive understanding of the factors causing scalp itch with the aim that this information will create new candidates to which treatment modalities can be designed. At least 12 (up to 20) subjects and similar number of control subjects without disease will have one clinic visit including questionnaires, testing of sensation on the scalp, and biopsy of the scalp.
Primary Outcome
Hypothesis: Scalp pruritus in patients with seborrheic dermatitis is associated with a change in the neuropeptide identity of nerves at the dermal-epidermal junction (DEJ).
Interventions
- PROCEDURE Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-07 |
What the finished NCT02349854 record still lists
NCT02349854 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biopsy is the first listed.
NCT02349854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02349854 about?
NCT02349854 is a clinical study titled "Neurobiology of the Scalp in Seborrheic Dermatitis". Seborrheic dermatitis is a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp or inside the ear. These scales can occur with or without underlying reddened skin. In addition to causing psychological distress, low self esteem, and ...
What is the current status of trial NCT02349854?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-02. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02349854?
The interventions under investigation include: Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02349854?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia